Based on these results, we propose that erythroid-specific expression of IGF2BP1 could provide dominant and curative levels of HbF in RBCs derived from transduced HSPCs of patients with SCD or severe β-thalassemia. The gene discussed is IGF2BP1; the disease is Schnyder corneal dystrophy.